US Patent 7098336 FXR NR1H4 nuclear receptor binding compounds
Patent 7098336 was granted and assigned to Phenex Pharmaceuticals on August, 2006 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7098336 FXR NR1H4 nuclear receptor binding compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
